

The FDA just approved Bixlenvo, a once-daily pill that's a game changer for people living with HIV who couldn't use existing single-pill treatments.

This breakthrough opens doors for about 5% of HIV patients in the U.

who've been managing complex medication regimens for decades.

Want to know more?